COMMUNIQUÉS West-GlobeNewswire
-
Delcath Announces 3rd Independent Safety Review of Randomized Trial Data for Metastatic Ocular Melanoma; Recommended Continuation with no Trial Modification
23/08/2018 - 17:14 -
Scapa Healthcare Granted European Patent for New Hydrocolloid Adhesive Composition
23/08/2018 - 16:00 -
Medifirst Solutions Announces Update for Its Time Machine Laser Division
23/08/2018 - 15:30 -
Obalon Therapeutics to Raise $10 Million in Private Placement
23/08/2018 - 15:02 -
Wildflower Brands Announces Official Uplisting to OTCQB Venture Market Exchange
23/08/2018 - 15:00 -
Konica Minolta Healthcare Supports the AAPM&R STEP Ultrasound Hands-on Learning Course with the SONIMAGE® HS1
23/08/2018 - 15:00 -
ReWalk Robotics to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6th
23/08/2018 - 15:00 -
AssistRx Supports Company Growth with Appointment of Executive Vice President, Data Solutions
23/08/2018 - 15:00 -
Scythian Biosciences Shifts Focus Exclusively to The United States as National Acceptance of Medical Cannabis Surges
23/08/2018 - 14:54 -
Assure Holdings to Resume Trading
23/08/2018 - 14:30 -
Avinger Completes Enrollment in SCAN Clinical Study
23/08/2018 - 14:30 -
Intellia Therapeutics to Host Educational Briefing Webinar on Interference Proceedings Relating to CRISPR/Cas9 Genome Editing Technology Patents
23/08/2018 - 14:30 -
Terra Tech Subsidiary, Edible Garden, Selected to Supply Organic Leafy Greens to Leading National Grocery Chains
23/08/2018 - 14:30 -
BrainStorm Cell Therapeutics Announces Successful Interim Safety Analysis in Phase 3 Trial of NurOwn® Therapy for ALS
23/08/2018 - 14:20 -
Forward Pharma to Participate in the LSX Nordic Congress
23/08/2018 - 14:00 -
Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
23/08/2018 - 14:00 -
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
23/08/2018 - 14:00 -
New Insights on Disease Burden for Hypertrophic Cardiomyopathy Patients Published in Circulation
23/08/2018 - 14:00 -
Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
23/08/2018 - 14:00
Pages